Live Breaking News & Updates on Receives Marketing Authorization

Stay updated with breaking news from Receives marketing authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates -September 21, 2023 at 01:01 am EDT

Product sales more than doubled in the first half of 2023 to €69.7 million compared to €33.3 million in the first half of 2022 Driven by IXIARO® and DUKORAL® sales, both of which benefited. ....

United States , New Zealand , United Kingdom , Instituto Butantan , Deerfield Orbimed , Joshua Drumm , European Union Horizon , Us Department Of Defense Do , Pan American Health Organization , Global Communications , Health Canada , European Union , Third Party , Coalition For Epidemic Preparedness Innovations , Drug Administration , Us Defense Logistics Agency , European Medicines Agency , Funds Deerfield , License Application , Euronext Paris , Financial Reports , Chief Financial Officer , Biologic License Application , Prescription Drug User Fee Act , Lancet Infectious Diseases , Epidemic Preparedness Innovations ,

VALNEVA: Valneva Reports Full Year 2022 Results and Provides Corporate Updates

Total revenues of €361.3 million in 2022 compared to €348.1 million in 2021 Driven by product sales of €114.8 million (82.3% increase compared to 2021), including €85.2 million of travel vaccine sales ....

New Zealand , United Kingdom , United Arab Emirates , United States , Kingdom Of Bahrain , Deerfield Orbimed , Instituto Butantan , Joshua Drumm , Vivalis Intercell , Tropical Disease Priority Review Voucher Program , Vaccines Announce European Partnership For Marketing , Global Communications , Drug Administration , European Commission For Valneva Inactivated , Pan American Health Organization , European Medicines Agency , Us Department Of Defense , European Union Member States , European Commission , European Union , Deerfield Management Company Orbimed , Coalition For Epidemic Preparedness Innovations , Euronext Paris , Chief Financial Officer , Biologics License Application , Prescription Drug User Fee Act ,

BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA

BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA MHRA marketing authorizations follow recent European Commission marketing authorizations  BRUKINSA is the only treatment authorized for MZL in Great. ....

United States , United Kingdom , South Korea , Northern Ireland , Great Britain , Mehrdad Mobasher , Kevin Mannix , Robert Mulrooney , Maryline Iva , Renata Walewska , European Commission , Regulatory Agency , Exchange Commission , National Institute For Health , European Union , University Hospitals Dorset , Department Of Hematology , Scottish Medicines Consortium , Receives Marketing Authorization , Chronic Lymphocytic Leukemia , Marginal Zone Lymphoma , Chief Medical Officer , General Manager , National Institute , Care Excellence , Northern Ireland Protocol ,

VALNEVA: Valneva Reports Further Heterologous Booster Data for its inactivated COVID-19 vaccine

Saint-Herblain (France), December 30, 2022 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further heterologous booster data from an exploratory, small clinical ....

United Arab Emirates , United Kingdom , Kingdom Of Bahrain , Adjuvanted Covid , Juan Carlos Jaramillo , Joshua Drumm , Global Communications , World Health Organization , Dynavax Technologies Corporation Nasdaq , Euronext Paris , Carlos Jaramillo , Chief Medical Officer , Dynavax Technologies Corporation , United Arab , European Investor , Global Investor , Announces Positive Homologous Booster Data , Inactivated Adjuvanted , Reports Further Positive Phase , First Heterologous Booster Results , Reports Nine Month , Provides Corporate Updates , Receives Marketing Authorization , Inactivated Whole Virus , Receives Conditional Marketing Authorization , Receives Emergency Use Authorization ,

NewsNow: Inflammatory Bowel Disease news

Read the latest Inflammatory Bowel Disease headlines, on NewsNow: the one-stop shop for Inflammatory Bowel Disease news ....

Krung Thep Mahanakhon , United States , United Kingdom , Australian Capital Territory , Hofseth Biocare , Russell Martin , Artizan Biosciences , Ashley Mansell , Eli Lilly , Pete Davidson , Bristol Myers Squibb , Nico Anelli , Rylan Clark , Newswise Press , Business Wire Press , Financial Reportglobenewswire Press , Business Updatesbusiness Wire Press , Kindex Pharmaceuticals , Corporate Updateglobenewswire Press , Business Updatesglobenewswire Press , Landos Biopharma Announces Leadership Transitionglobenewswire Press , Foundation Trust Press , University Of Oxford , Corporate Updatepr Newswire Press , Arena Pharmaceuticals Achieves Target Enrollment For Etrasimod , Qualiket Researchglobenewswire Press ,